The antioxidant and the DPPH free radical scavenging activity of 4-phenyl-3H-1,2-dithiole-3-thione (DT1), 5-(4-fluorophenyl)−3H-1,2-dithiole-3-thione (DT2), 5-(4-phenyl-3-thioxo-3H-1,2dithiol-5-yl)-benzo[d]oxazole-2(3H)thione (DT3) and 4-methyl-5-((phenylamino)methyl)−3H-1,2-dithiole-3-thione (DT4) was investigated using cyclic voltammetry (CV) and electronic spectroscopy (ES) assays. The diminution in anodic peak current density of an acetonitrile solution of DPPH in the absence and presence of gradually increasing amounts of 1,2-dithiole-3-thione derivatives (DT) was successfully exploited for measuring the antioxidant activity and the DPPH free radical scavenging activity. The EC50 values obtained from the CV and ES experiments suggested that all compounds had potential DPPH radical scavenging ability with the derivative DT3 possessing the highest potency of 21.5 ± 1.30 from CV and 20.6 ± 1.05 from ES. A molecular docking simulation indicated that all DT derivatives interacted with amino acid residues of glutathione reductase via hydrogen bonding and hydrophobic interactions. Based on the inhibitory concentration and docking score values, compound DT4 was the second inactive compound against the glutathione reductase enzyme having values equal to 41.4 µM and a docking score of −25.6 kJ/mol respectively. Toxicity perdition studies revealed that compounds DT1 and DT2 were non-toxic. GRAPHICAL ABSTRACT
Afzelin has been designed and tested for its in silico antibacterial activity against DNA gyrase complex of Staphyloccocus aureus. The results of the toxicity study indicate that afzelin displayed moderate antibacterial potential against staphylococcus aureus with LD50 = 5000 mg/Kg, which is almost four times and a half weaker than that obtained for the commercial antibiotic chloramphenicol. The afzelin and the commercial antibiotic chloramphenicol were subjected to docking studies to understand their interaction with DNA gyrase complex of Staphyloccocus aureus. Results indicated a good affinity of afzelin to the chosen target with the formation of four hydrogen bonds and binding energy of 29.82 KJ/mol. ADME study shows that afzelin is not inhibitors of CYP450 IA2, 2C19, 2C9, 2D6, 3A4 isoenzymes which suggests a decrease in their plasma concentrations and a rapid elimination route. Molecular dynamics simulations were performed for 10 ns for afzelin using the gromacs package to assess the conformational stability of protein-ligand complexes during the simulation.
Cyclic voltammetry (CV) and UV–Visible spectroscopy (UV–Vis) techniques were used to calculate binding parameters of 4-methyl-5-((phenylimino)methyl)-3H-1,2-dithiole-3-thione (MPDT) and 5-(4-fluorophenyl)-3H-1,2-dithiole-3-thione (FPDT) with DNA. The results obtained from both techniques were confirmed by computational molecular docking using AutoDock molecular docking software. The anodic peak potential shift in CV indicated an intercalative mode of binding. The binding constants (M−1) of the adducts MPDT-DNA and FPDT-DNA obtained from voltammetric measurements were found to be 8.0 × 104 and 2.4 × 104, respectively, with binding free energy being −27.99 and −25.01 KJ mol−1, respectively. These results are in good agreement with those obtained from UV–Visible spectroscopic studies. The diffusion coefficients of MPDT and FPDT (2.06 × 10−10 and 2.42 × 10−9, respectively) were found to be higher than those of DNA-bound compounds (1.27 × 10−10 and 1.65 × 10−9 cm2/s, respectively). The binding free energy of MPDT and FPDT to DNA was also calculated by molecular docking study. The docking study gave excellent approximation with experimental results, shedding light on the sites of binding.